A Body Shape Index as a Simple Anthropometric Marker for the Risk of Cardiovascular Events

Farina Mohamad Yusoff1, Masato Kajikawa2, Takayuki Yamaji1

  • 1Department of Regenerative Medicine, Division of Radiation Medical Science, Research Institute for Radiation Biology and Medicine, Hiroshima University, 1-2-3 Kasumi Minami-Ku, Hiroshima, 734-8553, Japan.

PubMed

Insights

A Body Shape Index (ABSI) effectively predicts cardiovascular event risk, offering a valuable tool beyond traditional Body Mass Index (BMI) for risk stratification. It highlights abdominal obesity

Area of Science:

  • Cardiology
  • Public Health
  • Anthropometry

Background:

  • Cardiovascular diseases (CVDs) remain a leading cause of mortality worldwide.
  • Traditional risk factors like Body Mass Index (BMI) have limitations in predicting CVD events.
  • Abdominal obesity is increasingly recognized as a significant risk factor for cardiovascular disease.

Purpose of the Study:

  • To review the predictive capabilities of the A Body Shape Index (ABSI) for cardiovascular events.
  • To assess ABSI's utility in cardiovascular risk stratification.

Main Methods:

  • Review of existing studies investigating the association between ABSI and cardiovascular outcomes.
  • Analysis of the ABSI formula, incorporating waist circumference, BMI, and height.
  • Evaluation of ABSI's performance in predicting major adverse cardiovascular events (MACE).

Main Results:

  • A high ABSI is independently associated with an increased incidence of cardiovascular events.
  • ABSI demonstrates utility in predicting cardiovascular mortality, nonfatal myocardial infarction, and nonfatal stroke.
  • Specific ABSI cutoff values can aid in identifying individuals with abdominal obesity and elevated cardiovascular risk.

Conclusions:

  • ABSI serves as a valuable tool for cardiovascular risk stratification, complementing traditional measures.
  • ABSI's inclusion of waist circumference enhances its ability to detect abdominal obesity-related risks.
  • Consideration of demographic and socioeconomic factors alongside ABSI is crucial for comprehensive risk assessment.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
43
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
264
Assessment of the Cardiovascular System II: Inspection01:29

Assessment of the Cardiovascular System II: Inspection

Inspection is the initial step in assessing the cardiovascular system. It involves a detailed visual examination that provides crucial information about a patient's circulatory and cardiac health. This systematic process, conducted from head to toe, helps identify signs of cardiovascular conditions by observing physical appearance, skin and mucous membranes, jugular and carotid pulsations, chest symmetry, and the condition of the extremities.
Head and Neck
165
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
371
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
497
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
86